Helicobacter creates immune system blind spot

By extracting cholesterol from host cell membranes, Helicobacter pylori generates “micro-islands”

More

NOXXON renegotiates ODIRNANE BSA financing agreement to remove unilateral option for investor to subscribe for tranches and to cancel existing warrants

 

NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), the “Company”, a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that it has renegotiated and signed an amendment to its...

More

KNAUER WINS GOLD STEVIE® AWARD IN THE 2018 GERMAN STEVIE AWARDS

KNAUER Wissenschaftliche Geräte GmbH was named the winner of a Gold Stevie® Award in the category

1. Best website (Chemical industry)

2. Entrepreneur of the year (Manufacturing and Production) 

3. Corporate social responsibility in the 2018 German...

More

ProBioGen and Surface Oncology Sign Second Antibody Manufacturing Program

Tumor Microenvironment Antibody, Parallel Cell Line Development till GMP Manufacturing

More

CO.DON – Strategic growth: establishment of Dutch subsidiary

Berlin / Teltow, 13 February 2018 – CO.DON AG, one of the leading providers of cell-based regenerative treatment methods for articular cartilage damage, has set up a subsidiary in the Netherlands, headquartered in Amsterdam. The establishment of...

More

Apply to present at Start-Up Challenge!

The Start-Up Challenge is a pitching competition offering emerging entrepreneurs a unique chance to pitch their company at DBT 2018, Germany’s largest biotech summit.

More

Eleven finalists have been chosen for the first ever Lyfebulb-Helsinn Innovation Summit & Award in Oncology

Lyfebulb, a patient empowerment platform that connects patients, industry and investors to support user-driven innovation in chronic diseases, and Helsinn, with activities focused on early-stage investments in areas of high unmet patient need, today...

More

German Accelerator Life Sciences Appoints Vice President Germany

The German Accelerator Life Sciences (GALS) has appointed Stefan B. Beerhalter as Vice President Germany. Mr. Beerhalter has more than 25 years of experience in the medical device industry and held various international and national senior management...

More

How cells stress-out differently

The release of stress hormones triggers a wide variety of different responses in the organism. Some of these responses are controlled by so-called enhancers, regulatory regions in the genome, which influence the activity of genes. Scientists at the...

More

Lymphoma reprograms immune cells to promote its own growth

Instead of defending the body against lymphoma, special immune cells sometimes have the opposite effect. The cancer reprograms the dendritic cells to promote lymphoma tumor growth. Researchers at the Max Delbrück Center for Molecular Medicine in the...

More
Show more items